Premium
Secukinumab shows high efficacy irrespective of HLA‐Cw6 status in patients with moderate‐to‐severe plaque‐type psoriasis: results from extension phase of the SUPREME study
Author(s) -
Papini M.,
Cusano F.,
Romanelli M.,
Burlando M.,
Stinco G.,
Girolomoni G.,
Peris K.,
Potenza C.,
Offidani A.,
Bartezaghi M.,
Aloisi E.,
Costanzo A.
Publication year - 2019
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.18013
Subject(s) - secukinumab , plaque psoriasis , medicine , psoriasis , human leukocyte antigen , immunology , dermatology , antigen , psoriatic arthritis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom